Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
BACKGROUND: The first cases of the coronavirus disease 2019 (COVID-19) were reported in Wuhan, China. No antiviral treatment options are currently available with proven clinical efficacy. However, preliminary findings from phase III trials suggest that remdesivir is an effective and safe treatment o...
Main Authors: | Azza Sarfraz, Zouina Sarfraz, Marcos Sanchez-Gonzalez, Jack Michel, George Michel, Odalys Frontela, Jorge Posada, Jose Cardona, Eugenio Angueira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Turkish Journal of Emergency Medicine |
Subjects: | |
Online Access: | http://www.turkjemergmed.org/article.asp?issn=2452-2473;year=2021;volume=21;issue=2;spage=43;epage=50;aulast=Sarfraz |
Similar Items
-
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
by: Chih-Jen Yang, et al.
Published: (2021-02-01) -
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
by: Richard D. Shih, et al.
Published: (2020-12-01) -
The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
by: Amirhossein Roshanshad, et al.
Published: (2020-10-01) -
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report
by: José A Gonzales-Zamora, et al.
Published: (2020-08-01) -
Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
by: Yu Ling Tan, et al.
Published: (2021-07-01)